Support PenkeUBS (Lux) Digital Health Equity SB USD
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCL.NASDAQ | Abcellera Biologics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.524 | 1.227 | 4.5m | $16.4m | $13.1m |
| |||||||||||||
| ARWR.NASDAQ | Arrowhead Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.964 | 2.305 | 1.2m | $1.8m | $23.5m |
| |||||||||||||
| ATRC.NASDAQ | AtriCure Inc | USA | Healthcare | Medical Instruments & Supplies | 2024-09-30 | 1.846 | 2.983 | 900k | $8.5m | $27.4m |
| |||||||||||||
| CLLS.NASDAQ | Cellectis SA | USA | Healthcare | Biotechnology | 2024-09-30 | 1.437 | 0.256 | 1.4m | $1.8m | $2.2m |
| |||||||||||||
| CRSP.NASDAQ | Crispr Therapeutics AG | USA | Healthcare | Biotechnology | 2024-09-30 | 0.599 | 2.508 | 510k | $11.5m | $20.8m |
| |||||||||||||
| DNLI.NASDAQ | Denali Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.889 | 3.319 | 1.2m | $9.9m | $26.7m |
| |||||||||||||
| DOCS.NYSE | Doximity Inc | USA | Healthcare | Health Information Services | 2024-09-30 | 0.49 | 2.908 | 910k | $4.3m | $53m |
| |||||||||||||
| EDIT.NASDAQ | Editas Medicine Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.909 | 0.217 | 750k | $1.5m | $907.5k |
| |||||||||||||
| EVH.NYSE | Evolent Health Inc | USA | Healthcare | Health Information Services | 2024-09-30 | 0.974 | 2.612 | 1.1m | $10.1m | $12.6m |
| |||||||||||||
| GH.NASDAQ | Guardant Health Inc | USA | Healthcare | Diagnostics & Research | 2024-09-30 | 0.817 | 2.285 | 1m | -$486k | $31.5m |
| |||||||||||||
| INSP.NYSE | Inspire Medical Systems Inc | USA | Healthcare | Medical Devices | 2024-09-30 | 0.972 | 3.511 | 290k | $6.5m | $54m |
| |||||||||||||
| IOVA.NASDAQ | Iovance Biotherapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.525 | 1.668 | 1.6m | $4m | $11.9m |
| |||||||||||||
| IRTC.NASDAQ | iRhythm Technologies Inc | USA | Healthcare | Medical Devices | 2024-09-30 | 0.911 | 2.062 | 285k | $653.5k | $25.4m |
| |||||||||||||
| KRYS.NASDAQ | Krystal Biotech Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.661 | 3.274 | 190k | $5.6m | $30.1m |
| |||||||||||||
| NARI.NASDAQ | Inari Medical Inc | USA | Healthcare | Medical Devices | 2024-09-30 | 1.11 | 3.142 | 650k | $4.8m | $34.8m |
| |||||||||||||
| NNOX.NASDAQ | Nano X Imaging Ltd | USA | Healthcare | Medical Devices | 2024-09-30 | 1.111 | 0.368 | 650k | $1.8m | $4.6m |
| |||||||||||||
| NVRO.NYSE | Nevro Corp | USA | Healthcare | Medical Devices | 2024-09-30 | 2.669 | 0.55 | 1m | $7.3m | $3.9m |
| |||||||||||||
| OPRX.NASDAQ | OPTIMIZERx Corp | USA | Healthcare | Health Information Services | 2024-09-30 | 1.692 | 0.213 | 310k | $1.9m | $1.5m |
| |||||||||||||
| PHR.NYSE | Phreesia Inc | USA | Healthcare | Health Information Services | 2024-10-31 | 2.483 | 2.637 | 1.4m | $6.3m | $36.3m |
| |||||||||||||
| RXRX.NASDAQ | Recursion Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.437 | 1.073 | 1.7m | $2.3m | $12.3m |
| |||||||||||||
| SDGR.NASDAQ | Schrodinger Inc | USA | Healthcare | Health Information Services | 2024-09-30 | 2.745 | 3.515 | 2m | $12.3m | $39.4m |
| |||||||||||||
| SOPH.NASDAQ | Sophia Genetics SA | USA | Healthcare | Health Information Services | 2024-09-30 | 3.311 | 0.787 | 2.2m | $3.7m | $6.9m |
| |||||||||||||
| TMDX.NASDAQ | TransMedics Group Inc | USA | Healthcare | Medical Devices | 2024-09-30 | 1.043 | 2.866 | 350k | $2m | $22.3m |
| |||||||||||||
| TWST.NASDAQ | Twist Bioscience Corp | USA | Healthcare | Diagnostics & Research | 2024-09-30 | 1.264 | 3.023 | 750k | $5.9m | $36.6m |
| |||||||||||||
| TXG.NASDAQ | 10X Genomics Inc | USA | Healthcare | Health Information Services | 2024-09-30 | 1.404 | 2.722 | 1.7m | $10.1m | $24.9m |
| |||||||||||||
| URGN.NASDAQ | UroGen Pharma Ltd | USA | Healthcare | Biotechnology | 2024-09-30 | 3.128 | 1.616 | 1.3m | $781.4k | $14.2m |
| |||||||||||||
| ZYME.NASDAQ | Zymeworks Inc. Common Stock | USA | Healthcare | Biotechnology | 2024-09-30 | 2.033 | 1.916 | 1.4m | $6.7m | $19.7m |
|
Trades
Adds
Report date: 2024-10-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| TMDX.NASDAQ | 80k | 29.6 | 11.7m | 80-177 | $63.90 | -20.0% |
Report date: 2024-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| NVRO.NYSE | 210k | 26.6 | 1.4m | 4-10 | $3.97 | -9.4% |
Report date: 2024-08-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| KRYS.NASDAQ | 25k | 15.2 | 4.7m | 159-219 | $158.52 | -0.1% |
| NVRO.NYSE | 430k | 119.4 | 3.4m | 4-10 | $3.97 | -9.4% |
| TXG.NASDAQ | 20k | 1.2 | 403.8k | 15-24 | $14.67 | -4.0% |
Report date: 2024-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| INSP.NYSE | 30k | 9.7 | 5.6m | 130-257 | $186.29 | 43.4% |
| SOPH.NASDAQ | 52.3k | 2.4 | 255.2k | 4-6 | $3.16 | -27.4% |
| URGN.NASDAQ | 120k | 10.0 | 1.7m | 11-21 | $10.82 | 2.1% |
Report date: 2024-05-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| SDGR.NASDAQ | 100k | 5.3 | 2.4m | 21-29 | $19.73 | -7.0% |
Reduces
Report date: 2024-10-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| DNLI.NASDAQ | -120k | -8.6 | -3.1m | 20-32 | $20.92 | 6.0% |
| EVH.NYSE | -40k | -3.4 | -1m | 20-34 | $11.27 | -44.1% |
| IRTC.NASDAQ | -5k | -1.7 | -348k | 56-90 | $89.37 | 59.8% |
| ZYME.NASDAQ | -18.4k | -1.3 | -221.5k | 9-14 | $14.14 | 50.3% |
Report date: 2024-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| DNLI.NASDAQ | -70k | -5.0 | -1.7m | 20-32 | $20.92 | 6.0% |
| EVH.NYSE | -40k | -3.4 | -1m | 18-34 | $11.27 | -37.3% |
| PHR.NYSE | -16.5k | -1.1 | -387.8k | 19-26 | $25.19 | 34.2% |
| ZYME.NASDAQ | -111.5k | -7.3 | -1.2m | 8-13 | $14.14 | 70.0% |
Report date: 2024-08-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| DOCS.NYSE | -190k | -17.3 | -5.6m | 25-38 | $58.27 | 133.0% |
| EVH.NYSE | -140k | -10.8 | -3.2m | 18-34 | $11.27 | -37.3% |
| ZYME.NASDAQ | -220k | -12.6 | -2.1m | 8-12 | $14.14 | 72.2% |
Report date: 2024-07-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| INSP.NYSE | -50k | -14.7 | -7.8m | 123-257 | $186.29 | 51.5% |
| NARI.NASDAQ | -30k | -4.4 | -1.4m | 41-60 | $53.65 | 30.6% |
| PHR.NYSE | -240k | -14.1 | -5.2m | 18-26 | $25.19 | 42.1% |
| TWST.NASDAQ | -70k | -8.5 | -3.4m | 30-61 | $48.90 | 61.3% |
| ZYME.NASDAQ | -50k | -2.8 | -459.1k | 8-11 | $14.14 | 72.2% |
Report date: 2024-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| CRSP.NASDAQ | -30k | -5.6 | -1.7m | 51-68 | $40.94 | -19.8% |
| IRTC.NASDAQ | -40k | -12.1 | -4m | 83-118 | $89.37 | 8.2% |
| KRYS.NASDAQ | -30k | -13.0 | -5m | 144-192 | $158.52 | 10.1% |
| TWST.NASDAQ | -255k | -23.7 | -10.3m | 27-55 | $48.90 | 78.4% |
Report date: 2024-05-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| DOCS.NYSE | -50k | -4.3 | -1.3m | 23-30 | $58.27 | 153.8% |
| GH.NASDAQ | -1m | -50.0 | -19.8m | 16-28 | $31.57 | 99.7% |
| IRTC.NASDAQ | -5k | -1.5 | -528.2k | 85-118 | $89.37 | 5.0% |
| KRYS.NASDAQ | -60k | -20.7 | -10m | 144-190 | $158.52 | 10.1% |
Comments
How you think about this?